Literature DB >> 19166848

Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L.

Gunter Schmidtke1, Birte Kalveram, Marcus Groettrup.   

Abstract

The ubiquitin-like modifier FAT10 targets proteins for degradation by the proteasome, a process accelerated by the UBL-UBA domain protein NEDD8 ultimate buster 1-long. Here, we show that FAT10-mediated degradation occurs independently of poly-ubiquitylation as purified 26S proteasome readily degraded FAT10-dihydrofolate reductase (DHFR) but not ubiquitin-DHFR in vitro. Interestingly, the 26S proteasome could only degrade FAT10-DHFR when NUB1L was present. Knock-down of NUB1L attenuated the degradation of FAT10-DHFR in intact cells suggesting that NUB1L determines the degradation rate of FAT10-linked proteins. In conclusion, our data establish FAT10 as a ubiquitin-independent but NUB1L-dependent targeting signal for proteasomal degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19166848     DOI: 10.1016/j.febslet.2009.01.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

Review 2.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

3.  FAT10 protein binds to polyglutamine proteins and modulates their solubility.

Authors:  Yu Nagashima; Hisatomo Kowa; Shoji Tsuji; Atsushi Iwata
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

4.  NEDD8 ultimate buster-1 long (NUB1L) protein promotes transfer of NEDD8 to proteasome for degradation through the P97UFD1/NPL4 complex.

Authors:  Shuai Liu; Hui Yang; Jian Zhao; Yu-Hang Zhang; Ai-Xin Song; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2013-09-09       Impact factor: 5.157

5.  Extended lifespan and reduced adiposity in mice lacking the FAT10 gene.

Authors:  Allon Canaan; Jason DeFuria; Eddie Perelman; Vincent Schultz; Montrell Seay; David Tuck; Richard A Flavell; Michael P Snyder; Martin S Obin; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

6.  FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis.

Authors:  Neha Rani; Annette Aichem; Gunter Schmidtke; Stefan G Kreft; Marcus Groettrup
Journal:  Nat Commun       Date:  2012-03-20       Impact factor: 14.919

7.  The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.

Authors:  Annika N Boehm; Johanna Bialas; Nicola Catone; Almudena Sacristan-Reviriego; Jacqueline van der Spuy; Marcus Groettrup; Annette Aichem
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

8.  Disruption of FAT10-MAD2 binding inhibits tumor progression.

Authors:  Steven Setiawan Theng; Wei Wang; Way-Champ Mah; Cheryl Chan; Jingli Zhuo; Yun Gao; Haina Qin; Liangzhong Lim; Samuel S Chong; Jianxing Song; Caroline G Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

9.  SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model.

Authors:  Fawzia Bardag-Gorce; Joan Oliva; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-03-16       Impact factor: 3.362

10.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.